NDC 70000-0239-01 - Leader Ibuprofen
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70000-0239
- Requested NDC
- 70000-0239-01
- Package NDCs from labels
- 70000-0239-1, 70000-0239-01
- Manufacturer
- Cardinal Health 110, LLC. dba Leader
- Effective date
- 2025-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Leader Ibuprofen - Cardinal Health 110, LLC. dba Leader | Cardinal Health 110, LLC. dba Leader | 2025-08-28 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70000-0239-1 | Leader Ibuprofen | 24 in 1 BOTTLE | TABLET, CHEWABLE | 24 | 5 | |
| 70000-0239-1 | Leader Ibuprofen | 1 in 1 CARTON | TABLET, CHEWABLE | 1 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70000-0239 | LEADER IBUPROFEN (IBUPROFEN) TABLET, CHEWABLE [CARDINAL HEALTH 110, LLC. DBA LEADER] | 4 | Current NDC, Legacy NDC, 2 package rows | 20210624_5975c324-2906-4e71-9b88-2e772d9fbfde.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 70000-0239-1 | EA - Each | 70000-0239 | 7c50a956-641c-49d0-977d-2f9de47410d7 | 1 | 2017-11-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibuprofen | IBUPROFEN | Proficient Rx LP | 9e9fb921-6b6a-422e-95b6-41d6b9047b80 | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| DG Health childrens ibuprofen | IBUPROFEN | Dolgencorp, LLC | 0fd6fcca-cbfe-48af-80dd-2607b5d51b53 | 2022-10-13 | Warnings | WK2XYI10QM |
| Circle K Ibuprofen | IBUPROFEN | Lil Drug Store Products, Inc | 791a7375-34b2-449b-9284-3c49a2704619 | 2022-10-11 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PharmPak, Inc. | b493bf76-1e8b-4e72-bef6-aca4efc69cbe | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PharmPak, Inc. | 4d95bccd-8280-4d03-a574-927669c7cda0 | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | PharmPak, Inc. | bb6d0547-c113-42f9-8bf2-c227a55ab758 | 2022-10-09 | Boxed warning, Warnings, Adverse reactions | WK2XYI10QM |
| Circle K Ibuprofen | IBUPROFEN | Lil Drug Store Products, Inc | 805d9d80-7de7-49d9-afdb-3a645059fe35 | 2022-09-21 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Aurohealth LLC | e1b49257-d226-457f-8f2d-9a757a65bbcb | 2022-09-06 | Warnings | WK2XYI10QM |
| Hendel Periodontal and Tooth Pain Relief | SODIUM BORATE, TRIBASIC CALCIUM PHOSPHATE, MERCURIUS SOLUBILIS, AND SILICON DIOXIDE | MediNatura Inc | f34e9f77-69fd-4c7f-9eea-2d721a4d27fb | 2022-08-22 | Warnings | ETJ7Z6XBU4 |
| Diphenhydramine HCl and Ibuprofen | DIPHENHYDRAMINE HCL AND IBUPROFEN | Aurohealth LLC | 2c7c5349-06c9-401a-88e9-8f91ddb7f91a | 2022-08-19 | Warnings | WK2XYI10QM |
| Ibuprofen Oral | IBUPROFEN ORAL | Strategic Sourcing Services | a3062142-db0e-4758-a762-2b2bb05670b1 | 2022-08-10 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN TABLET, FILM-COATED | Lil' Drug Store Products, Inc. | e5bf5e09-7d42-6314-e053-2a95a90a2325 | 2022-08-08 | Warnings | WK2XYI10QM |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare CORP | 069460a5-3e9a-428f-b2dc-3405690f4fd7 | 2022-07-25 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | 55609586-f0b4-42e6-8dd9-cd090afb5dca | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I.V. FAT EMULSION | Baxter Healthcare Corporation | a69c82da-15ba-4d4d-8d7f-871dc3981eb8 | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Intralipid | I. V. FAT EMULSION | Baxter Healthcare Corporation | dd269651-30e8-43f0-880f-484346eaafeb | 2022-07-21 | Boxed warning, Adverse reactions | 241ATL177A |
| Ibuprofen | IBUPROFEN | DOLGENCORP, INC. | df321783-73cb-55bf-e053-2a95a90a4ce2 | 2022-07-07 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | Proficient Rx LP | b7565aac-a928-4116-b9af-cf636da4537c | 2022-07-01 | Warnings | WK2XYI10QM |
| Ibuprofen and Diphenhydramine Citrate | IBUPROFEN AND DIPHENHYDRAMINE CITRATE | Aurohealth LLC | 21c1f5c5-19fa-4a59-bad3-ea85fd37471b | 2022-06-03 | Warnings | WK2XYI10QM |
| Ibuprofen | IBUPROFEN | CARDINAL HEALTH | dfbbde4f-633d-6d57-e053-2a95a90ad82f | 2022-05-24 | Warnings | WK2XYI10QM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.